Apple’s shares are expected to drop Oppenheimer reduced its profits per share estimate for the year 2026 by 4% to $7.95 – less than the average estimate of $8.23. The company now thinks Apple ...

Dane DeHaan (American Primeval, Oppenheimer) has been tapped for a major recurring role opposite leads Callum Turner and ...

Dane DeHaan is the latest addition to the cast of the "Neuromancer" series currently in the works at Apple TV+.

Apple (AAPL, Financials) was downgraded to Perform from Outperform by Oppenheimer ahead of its first-quarter fiscal 2025 earnings report, with analysts citing slowing iPhone sales and competitive ...

Dane DeHaan (“American Primeval,” “Oppenheimer)” has been tapped for a major recurring role opposite leads Callum Turner and ...